ASTEX PHARMACEUTICALS, INC Shareholders' Equity
ASTEX PHARMACEUTICALS, INC had Shareholders' Equity of $233.00 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2013-08-09
- 2013-06-30: Stockholders' Equity Attributable to Parent $233.00M.
- 2013-03-31: Stockholders' Equity Attributable to Parent $233.12M.
- 2012-12-31: Stockholders' Equity Attributable to Parent $236.94M.
- 2012-09-30: Stockholders' Equity Attributable to Parent $232.49M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2013-06-30 | $233.00M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $233.12M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $236.94M 10-Q · filed 2013-08-09 |
| 2012-09-30 | $232.49M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $228.40M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $231.58M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $220.00M 10-K · filed 2013-03-18 |
| 2011-09-30 | $221.23M 10-Q · filed 2011-11-09 |
| 2010-12-31 | $121.61M 10-K · filed 2013-03-18 |
| 2009-12-31 | $101.99M 10-K · filed 2013-03-18 |
| 2008-12-31 | $90.49M 10-K · filed 2012-03-15 |